[1]
Kirkpatrick, PhD, D.L., Schmidt, PhD, W.K., Morales, BSc, R., Cremin, PhD, J., Seroogy, BSc, J., Husfeld, PhD, C. and Jenkins, PhD, T. 2017. In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone. Journal of Opioid Management. 13, 1 (Jan. 2017), 39–49. DOI:https://doi.org/10.5055/jom.2017.0366.